Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions

Figure 2 US-guided radiofrequency ablation of hepatocellular carcinoma. A: Gd-EOB- DTPA enhanced MR image of a 57 years old cirrhotic patient with a 1.5-cm liver nodule in segment VIII (arrow), showing enhancement in the arterial phase, in keeping with HCC. B: US image demonstrating the RF needle, with a 3 cm exposed tip, crossing the lesion (arrow). C: 1-mo follow-up portal-venous phase Gd-EOB- DTPA enhanced MR image demonstrating the oval shaped ablation zone (arrow).